Yuichiro Yabe

1.3k total citations
54 papers, 684 citations indexed

About

Yuichiro Yabe is a scholar working on Rheumatology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Yuichiro Yabe has authored 54 papers receiving a total of 684 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Rheumatology, 14 papers in Organic Chemistry and 11 papers in Molecular Biology. Recurrent topics in Yuichiro Yabe's work include Rheumatoid Arthritis Research and Therapies (17 papers), Systemic Lupus Erythematosus Research (9 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Yuichiro Yabe is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (17 papers), Systemic Lupus Erythematosus Research (9 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Yuichiro Yabe collaborates with scholars based in Japan, United Kingdom and United States. Yuichiro Yabe's co-authors include Naoki Ishiguro, Takuya Shimizu, Kunio Hiwada, Yasuteru Iijima, Toshihisa Kojima, Takeshi Kokubu, Atsushi Kaneko, Daniel H. Rich, Dominique Guillaume and Hiroshi Fukumi and has published in prestigious journals such as Journal of the American Chemical Society, Journal of the American College of Cardiology and Scientific Reports.

In The Last Decade

Yuichiro Yabe

50 papers receiving 649 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuichiro Yabe Japan 16 264 193 117 115 74 54 684
Florian Colbatzky Germany 12 318 1.2× 50 0.3× 154 1.3× 36 0.3× 88 1.2× 26 816
Julia Paik New Zealand 14 234 0.9× 97 0.5× 39 0.3× 46 0.4× 99 1.3× 28 765
Krishnendu Roy United States 13 762 2.9× 212 1.1× 56 0.5× 14 0.1× 53 0.7× 24 1.1k
Richard A. McReynolds United States 11 130 0.5× 133 0.7× 25 0.2× 127 1.1× 69 0.9× 14 854
W.L. van Noort Netherlands 15 364 1.4× 34 0.2× 71 0.6× 23 0.2× 89 1.2× 30 655
Jörg Hartmann Germany 6 215 0.8× 40 0.2× 34 0.3× 25 0.2× 73 1.0× 8 577
Scot Middleton United States 13 387 1.5× 221 1.1× 45 0.4× 12 0.1× 59 0.8× 15 770
Nobuyuki Baba Japan 17 267 1.0× 48 0.2× 32 0.3× 21 0.2× 147 2.0× 49 789
M. Kamiyama United States 13 414 1.6× 52 0.3× 32 0.3× 23 0.2× 61 0.8× 34 951
Michael Silverberg United States 14 245 0.9× 82 0.4× 26 0.2× 49 0.4× 41 0.6× 33 991

Countries citing papers authored by Yuichiro Yabe

Since Specialization
Citations

This map shows the geographic impact of Yuichiro Yabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuichiro Yabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuichiro Yabe more than expected).

Fields of papers citing papers by Yuichiro Yabe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuichiro Yabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuichiro Yabe. The network helps show where Yuichiro Yabe may publish in the future.

Co-authorship network of co-authors of Yuichiro Yabe

This figure shows the co-authorship network connecting the top 25 collaborators of Yuichiro Yabe. A scholar is included among the top collaborators of Yuichiro Yabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuichiro Yabe. Yuichiro Yabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Asai, Shuji, Nobunori Takahashi, Tomonori Kobayakawa, et al.. (2021). Comparison of the effects of baricitinib and tocilizumab on disease activity in patients with rheumatoid arthritis: a propensity score matching analysis. Clinical Rheumatology. 40(8). 3143–3151. 7 indexed citations
2.
Takahashi, Nobunori, Shuji Asai, Tomonori Kobayakawa, et al.. (2020). Predictors for clinical effectiveness of baricitinib in rheumatoid arthritis patients in routine clinical practice: data from a Japanese multicenter registry. Scientific Reports. 10(1). 21907–21907. 20 indexed citations
3.
Ogawa, Yoshikazu, Nobunori Takahashi, Atsushi Kaneko, et al.. (2019). Association between seropositivity and discontinuation of tumor necrosis factor inhibitors due to ineffectiveness in rheumatoid arthritis. Clinical Rheumatology. 38(10). 2757–2763. 15 indexed citations
4.
Hattori, Yosuke, Toshihisa Kojima, Atsushi Kaneko, et al.. (2016). Longterm Retention Rate and Risk Factors for Adalimumab Discontinuation Due To Efficacy and Safety in Japanese Patients with Rheumatoid Arthritis: An Observational Cohort Study. The Journal of Rheumatology. 43(8). 1475–1479. 3 indexed citations
5.
Fujibayashi, Takayoshi, Nobunori Takahashi, Daihei Kida, et al.. (2015). Comparison of efficacy and safety of tacrolimus and methotrexate in combination with abatacept in patients with rheumatoid arthritis; a retrospective observational study in the TBC Registry. Modern Rheumatology. 25(6). 825–830. 13 indexed citations
6.
Kobayakawa, Tomonori, Toshihisa Kojima, Nobunori Takahashi, et al.. (2014). Drug retention rates of second biologic agents after switching from tumor necrosis factor inhibitors for rheumatoid arthritis in Japanese patients on low-dose methotrexate or without methotrexate. Modern Rheumatology. 25(2). 251–256. 13 indexed citations
8.
Kojima, Toshihisa, Atsushi Kaneko, Y. Hirano, et al.. (2011). Early aggressive intervention with tocilizumab for rheumatoid arthritis increases remission rate defined using a Boolean approach in clinical practice. Modern Rheumatology. 22(3). 370–375. 18 indexed citations
9.
Hayakawa, Ichiro, Atsushi Kasuya, Shuichi Miyamoto, et al.. (1999). Structure–activity relationship of HIV-1 protease inhibitors containing α-hydroxy-β-amino acids. Detailed study of P 1 site. Bioorganic & Medicinal Chemistry. 7(9). 2063–2072. 15 indexed citations
10.
Komai, Tomoaki, Hiroshi Handa, Hiroshi Mohri, et al.. (1997). In Vitro and Ex Vivo Anti-human Immunodeficiency Virus (HIV) Activities of a New Water-Soluble HIV Protease Inhibitor, R-87366, Containing (2S,3S)-3-Amino-2-hydroxy-4-phenylbutanoic Acid.. Biological and Pharmaceutical Bulletin. 20(2). 175–180. 2 indexed citations
11.
Yabe, Yuichiro, et al.. (1997). Effect of Dibutyryl Cyclic Adenosine Monophosphate on Skeletal Muscle Reperf usion Injury in the Rat. European Surgical Research. 29(6). 438–446. 5 indexed citations
12.
Yabe, Yuichiro, et al.. (1996). A Perfluorochemical Prevents Ischemia–Reperfusion Injury of Muscle. Journal of Surgical Research. 64(1). 89–94. 4 indexed citations
13.
Komai, Tomoaki, Atsushi Kasuya, Hiroshi Handa, et al.. (1996). Structure-activity relationships of HIV-1 PR inhibitors containing AHPBA—II. Modification of pyrrolidine ring at P1′ proline. Bioorganic & Medicinal Chemistry. 4(8). 1365–1377. 9 indexed citations
15.
Komai, Tomoaki, et al.. (1994). Structure-activity relationships of HIV-1 PR inhibitors containing AHPBA. Bioorganic & Medicinal Chemistry. 2(8). 807–825. 17 indexed citations
16.
Yabe, Yuichiro, et al.. (1994). Morphologic and Metabolic Study of the Effect of Oxygenated Perfluorochemical Perfusion on Amputated rabbit limbs. Journal of Reconstructive Microsurgery. 10(3). 185–191. 15 indexed citations
17.
Ishiguro, Naoki, et al.. (1994). Basic Fibroblast Growth Factor Has a Beneficial Effect on the Viability of Random Skin Flaps in Rats. Annals of Plastic Surgery. 32(4). 356–360. 45 indexed citations
18.
Nishi, Takahide, Mikayo Kataoka, Yusuke Morisawa, et al.. (1990). Syntheses and biological activities of renin inhibitors containing statine analogues.. Chemical and Pharmaceutical Bulletin. 38(1). 103–109. 16 indexed citations
19.
Kokubu, Takeshi, Kunio Hiwada, E Murakami, et al.. (1987). In Vitro Inhibition of Human Renin by Statine-Containing Tripeptide Renin Inhibitor (ES-1005). Journal of Cardiovascular Pharmacology. 10. 88–90. 10 indexed citations
20.
Fukumi, Hiroshi, Robert T. Grammer, K S Misono, et al.. (1984). Synthesis of atrial natriuretic peptides and studies on structural factors in tissue specificity. Biochemical and Biophysical Research Communications. 123(1). 338–344. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026